Abstract:Previously we have shown that AIP1 (apoptosis signal-regulating kinase [ASK]1-interacting protein 1), a novel member of the Ras-GAP protein family, facilitates dephosphorylation of ASK1 at pSer967 and subsequently 14-3-3 release from ASK1, leading to enhanced ASK1-JNK signaling. However, the phosphatase(s) responsible for ASK1 dephosphorylation at pSer967 has not been identified. In the present study, we identified protein phosphatase (PP)2A as a potential phosphatase in vascular endothelial cells (ECs). Tumor necrosis factor (TNF)-induced dephosphorylation of ASK1 pSer967 in ECs was blocked by PP2A inhibitor okadaic acid. Overexpression of PP2A catalytic subunit induced dephosphorylation of ASK1 pSer967 and activation of c-Jun N-terminal kinase (JNK). In contrast, a catalytic inactive form of PP2A or PP2A small interfering RNA blunted TNF-induced dephosphorylation of ASK1 pSer967 and activation of JNK without effects on NF-kappaB activation. Whereas AIP1, via its C2 domain, binds to ASK1, PP2A binds to the GAP domain of AIP1. Endogenous AIP1-PP2A complex can be detected in the resting state, and TNF induces a complex formation of AIP1-PP2A with ASK1. Furthermore, TNF-induced association of PP2A with ASK1 was diminished in AIP1-knockdown ECs, suggesting a critical role of AIP1 in recruiting PP2A to ASK1. TNF-signaling molecules TRAF2 and RIP1, known to be in complex with AIP1 and activate AIP1 by phosphorylating AIP1 at Ser604, are critical for TNF-induced ASK1 dephosphorylation. Finally, PP2A and AIP1 cooperatively induce activation of ASK1-JNK signaling and EC apoptosis, as demonstrated by both overexpression and small interfering RNA knockdown approaches. Taken together, our data support a critical role of PP2A-AIP1 complex in TNF-induced activation of ASK1-JNK apoptotic signaling.

The IAP family: endogenous caspase inhibitors with multiple biological activities

The IAP family: endogenous caspase inhibitors with multiple biological activities

Distinct Domains for Anti- and Pro-apoptotic Activities of IEX-1

Inhibitor of Apoptosis Proteins and Apoptosis

AIP1 is Critical in Transducing IRE1-mediated Endoplasmic Reticulum Stress Response

AIP1 Recruits Phosphatase PP2A to ASK1 in Tumor Necrosis Factor–Induced ASK1-JNK Activation

XIAP as a multifaceted molecule in Cellular Signaling

Comprehensive Molecular Characterization of Inhibitors of Apoptosis Proteins (iaps) for Therapeutic Targeting in Cancer

Antagonists of IAP proteins: novel anti-tumor agents.

Advances in the Research of Inhibitor-of-Apoptosis Protein XIAP

Structural Basis of IAP Recognition by Smac/DIABLO

Advances in studies on inhibitor of apoptosis proteins

Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives.

Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells

An inhibitor of apoptosis protein ( Es IAP1) from Chinese mitten crab Eriocheir sinensis regulates apoptosis through inhibiting the activity of Es Caspase-3/7-1

Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.

Mechanism of XIAP-Mediated Inhibition of Caspase-9

DCAF12 promotes apoptosis and inhibits NF-kappa B activation by acting as an endogenous antagonist of IAPs

DCAF12 promotes apoptosis and inhibits NF-κB activation by acting as an endogenous antagonist of IAPs

Molecular Dynamics Simulation Revealed the Intrinsic Conformational Change of Cellular Inhibitor of Apoptosis Protein-1

Advances in IκB Protein Family Research